Case Study | Life Sciences
Empowering scalable delivery and cost transparency through a modernized Platform per Project model.
A global biopharmaceutical enterprise sought to overcome the limits of a shared DevOps account model that hindered scalability, governance, and cost transparency. Competing projects, centralized ownership, and single-region availability slowed innovation and reduced financial visibility across teams.
Brillio partnered with the client to reimagine their DevOps environment through a Platform-per-Project model, introducing automation, multi-region deployment, and real-time cost tracking. The AWS-powered transformation empowered teams with autonomy and control while ensuring strong governance and 100% cost accountability, enabling enterprise to operate on a scalable, transparent, and future-ready DevOps foundation that accelerates delivery, strengthens compliance, and aligns technology outcomes with business growth.
Discover how Brillio helps global enterprises modernize DevOps with automation, governance, and speed.